Johan Karl Olov Skog

This inventor holds 24 USPTO granted patents and 30 published patent applications, plus 8 CIPO patents and 19 EPO patents, primarily in Extracellular Vesicle Isolation. Top assignees: Exosome Diagnostics, Inc., The General Hospital Corporation, The Brigham and Women's Hospital, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johan Karl Olov Skog. Retrieved from https://idiyas.com/inventor/johan-karl-olov-skog

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 30)

% Patents Active = 100.0

CIPO Patents = 8 (Patent Applications = 2)

EPO Patents = 19 (Patent Applications = 35)

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 44(Granted Patents)

Location History:

Cambridge, MA (US) (2019)
New York, NY (US) (2019 - 2022)
Charlestown, MA (US) (2019 - 2024)
Lincoln, MA (US) (2019 - 2024)

Company Filing History:

16 out of 20

Exosome Diagnostics, Inc.

patents

7 out of 3,079

The General Hospital Corporation

patents

2 out of 1,430

The Brigham and Women's Hospital, Inc.

patents

4. 1 out of 113

Exact Sciences Corporation

patents

where one patent can have more than one assignee

Years Active: 2019-2026

Loading Chart...

Areas of Expertise:

Extracellular Vesicles

Nucleic Acid Extraction

Microvesicles

Biofluids

Cancer Diagnosis

Renal Transplant Rejection

Mutation Detection

Parkinson's Disease

Assay Controls

Cell-Free DNA

Biological Samples

Compositions

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735695 - Automated and manual methods for isolation of extracellular vesicles and co-isolation of cell-free DNA from biofluids (2026-09-15),

2. 12497631 - Use of Microvesicles in the Treatment of Medical Conditions (2025-12-16),

3. 12493029 - Compositions, methods, and kits for the isolation of extracellular vesicles (2025-12-09),

4. 12312582 - Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom (2025-05-27),

5. 12258587 - Compositions and methods for internal controls of microvesicle isolations (2025-03-25),

6. 12018334 - Controls for nucleic acid assays (2024-06-25),

7. 11899024 - Treatment and diagnosis of parkinson's disease using isolated and enriched populations of biofluid-derived extracellular vesicles (2024-02-13),

8. 11891664 - Methods of detecting renal transplant rejection using microvesicle nucleic acid biomarkers (2024-02-06),

9. 11519036 - Use of microvesicles in analyzing nucleic acid profiles (2022-12-06),

10. 11427864 - Methods and compositions to detect mutations in plasma using exosomal RNA and cell free DNA from non-small cell lung cancer patients (2022-08-30),

11. 11407991 - Nucleic acid extraction from heterogeneous biological materials (2022-08-09),

12. 11268085 - Methods for isolating microvesicles and extracting nucleic acids from biological samples (2022-03-08),

13. 11214833 - Profiling microvesicle nucleic acids and uses thereof as signatures in diagnosis of renal transplant rejection (2022-01-04),

14. 11155874 - Use of microvesicles in analyzing mutations (2021-10-26),

15. 11136627 - Controls for nucleic acid assays (2021-10-05),

Title: **Johan Karl Olov Skog: Innovator in Microvesicle Isolation**

Introduction

Johan Karl Olov Skog is a prominent inventor based in Lincoln, MA, whose work has significantly impacted the field of biomedical research through his 20 patents. His innovations focus on methods and compositions for the isolation of microvesicles, a crucial area in the advancement of diagnostics and therapeutic applications.

Latest Patents

Skog's latest patents represent vital contributions to the field. One of his notable patents is centered around "Compositions and methods for internal controls of microvesicle isolations." This patent provides innovative compositions and methods that utilize enveloped viruses, such as inactive mouse hepatitis virus (MHV), to serve as internal controls during microvesicle isolation. Another significant invention by Skog is focused on "Controls for nucleic acid assays," which includes a method and kit for isolating microvesicles or extracting nucleic acids from biological samples using control particles. These control particles, which can include viruses or virus-like particles, play a crucial role in ensuring the accuracy and reliability of nucleic acid extraction and microvesicle isolation processes.

Career Highlights

Throughout his career, Johan Karl Olov Skog has contributed to various prestigious organizations. He has worked with Exosome Diagnostics, Inc., where he utilized his expertise in microvesicle research to develop innovative diagnostic solutions. Additionally, he has been associated with The General Hospital Corporation, further emphasizing his commitment to advancing medical research through his patents.

Collaborations

Skog has collaborated with esteemed colleagues, including Mikkel Noerholm and Leileata M Russo. Their combined efforts have enhanced the field's understanding of microvesicle biology and diagnostics, culminating in impactful research findings and patented technologies.

Conclusion

Johan Karl Olov Skog exemplifies innovation in the realm of microvesicle research. His extensive patent portfolio underlines his dedication to improving diagnostic methodologies and therapeutic approaches. With continued collaboration and research, Skog's contributions will likely pave the way for further advancements in biomedical science, highlighting his significant role as an inventor in this essential field.

Profile summary based on public USPTO records.